Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Minerva Neuroscie (NQ: NERV )

3.300 USD +0.020 (+0.61%)
Streaming Delayed Price Updated: 8:01 AM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 281
Open 3.280
Bid (Size) 3.280 (1)
Ask (Size) 3.470 (1)
Prev. Close 3.280
Today's Range 3.280 - 3.410
52wk Range 1.810 - 15.21
Shares Outstanding 38,749,343
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CLASS ACTION UPDATE for NERV, SWI and QSR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
From ACCESSWIRE
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Minerva Neurosciences, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Cont
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017 and November 30, 2020, inclusive (the "Class... 
From PR Newswire

Performance

YTD
+38.66%
+38.66%
1 Month
+39.83%
+39.83%
3 Month
+0.92%
+0.92%
6 Month
-9.09%
-9.09%
1 Year
-59.66%
-59.66%

More News

Read More
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Northern Dynasty Minerals, Splunk, Minerva Neurosciences, and Covia Holdings and Encourages Investors t
From GlobeNewswire News Releases
NERV DEADLINE: Zhang Investor Law Reminds Investors with Losses of the Deadline in Securities Class Action Lawsuit Against Minerva Neurosciences, Inc. – NERV
From GlobeNewswire News Releases
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BRY, NERV and OTGLY
From ACCESSWIRE
Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neurosciences
From GlobeNewswire News Releases
Minerva Neurosciences and Royalty Pharma Announce Sale of Seltorexant Royalty for up to $155 Million
From GlobeNewswire News Releases
ROSEN, A LEADING LAW FIRM, Reminds Minerva Neurosciences, Inc. Investors of Important February 8 Deadline in Securities Class Action – NERV
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Block & Leviton LLP Reminds Shareholders that it Has Filed a Lawsuit Against Minerva Neurosciences, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm
From GlobeNewswire News Releases
SHAREHOLDER ALERT: BSX NERV KNDI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
From ACCESSWIRE
CLASS ACTION UPDATE for LRN, NERV and QIWI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
From ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.